This study illustrated while increased miR-205 could directly repress PHLPP2 expression and activate the AKT/Mechanistic Target of Rapamycin (mTOR) signaling pathways in multiple NSCLC cell lines (78) (Figure 3 and Table 1). The gene discussed is AKT1; the disease is non-small cell lung carcinoma.